ADVERTISEMENT

Conference Report

ADA 2022 — Is obesity the primary therapeutic target in type 2 diabetes?

Drishti Agarwal   |   10 June 2022

An intriguing debate session at the 82 nd Scientific Sessions of the American Diabetes Association (ADA), saw Ildiko Lingvay, MD, MPH, MSCS and Jeffrey Mechanick, MD argue whether the treatment of type 2 diabetes (T2D) should be centered around weight loss or glycemic control.

Ildiko Lingvay (University of Texas Southwestern Medical...

          

November Challenge

Ends in 1d 5h
left
right

Topic Challenges

left
right